New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and iron-modulating activity - key to its broader epigenetic mechanism of action.
Read MoreConsolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturers
Integration of technology and physical infrastructure positions Wellgistics with the "Pharmacy IT Railroad" to execute on PharmacyChain™ smart contracts for optimized healthcare delivery in the $634 billion United States prescription drug market
With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market.
Read MoreThird Quarter Highlights
Per Class B share(3): $1.21 adjusted basic earnings up 11.0%; $1.21 basic earnings up 12.0%
Sales increased 6.3% on 3.7% organic growth, 0.1% acquisition growth and 2.5% positive currency translation
Operating income(1) improved 11.4%, with a 16.4% operating margin(1) up 80 bps
Returned $155.8 million to shareholders: $55.8 million in dividends and repurchased 1.3 million Class B shares for $100.0 million
Nine-Month Highlights
Per Class B share(3): $3.61 adjusted basic earnings up 9.4%; $3.60 basic earnings down 3.2%; 2024 included $0.44 revaluation gain in basic earnings
Sales increased 6.5% on 3.1% organic growth, 0.8% acquisition growth and 2.6% positive currency translation
Operating income(1) improved 9.9%, with a 16.6% operating margin(1) up 50 bps
Returned $467.9 million to shareholders: $167.9 million in dividends and repurchased 3.9 million Class B shares for $300.0 million
Increased ARR Leads to Higher Revenue and EBITDA
Q3 2025 revenue grew modestly to $5.7M compared to $5.6M in Q2 2025 and Q3 2024
Q3 Adjusted EBITDA increased 71% to $933,000 compared to $546,000 in Q3 2024
Gross margin percentage remained strong at 75%
- Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated
Read More
Founded by veteran offensive cyber experts, Tenzai introduces an AI agentic penetration testing platform that actively hacks, exploits, and fixes hardest-to-find vulnerabilities across enterprise software at the speed of AI.
Read More
Through Operation Rooftop, TAMKO and the Kansas City Chiefs continue their shared mission to support veterans and military families, honoring their service with American manufactured quality and lasting protection.
Read More